• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺癌幸存者后续原发性癌症的风险:一项基于全国人口的研究。

Risk of Subsequent Primary Cancer in Thyroid Cancer Survivors: A Nationwide Population-Based Study.

作者信息

Kim Min-Su, Lee Sang Jun, Lee Myeong Hoon, Choi Jay Hyug, Han Hyun Wook, Song Young Shin

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, CHA Bundang Medical Center, CHA University School of Medicine, CHA University, Seongnam 13496, Republic of Korea.

Department of Biomedical Informatics, CHA University School of Medicine, CHA University, Seongnam 13496, Republic of Korea.

出版信息

Diagnostics (Basel). 2023 Sep 11;13(18):2903. doi: 10.3390/diagnostics13182903.

DOI:10.3390/diagnostics13182903
PMID:37761273
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10527961/
Abstract

Despite obtaining a good prognosis and long life expectancy, survivors of thyroid cancer can nevertheless develop subsequent primary cancer (SPC). We investigated the risk and types of SPC in patients with thyroid cancer and compared them with subjects without thyroid cancer history (controls). We conducted a nationwide, population-based, retrospective cohort study based on the Korean National Health Insurance Database. A total of 432,654 patients diagnosed with thyroid cancer between 2004 and 2019 were 1:1 matched with controls for age, sex, income, and region of residence. The hazard ratios (HR) and 95% confidence intervals (CI) of SPC were estimated using Cox proportional hazard models. In total, 78,584 (18.2%) patients with thyroid cancer and 49,979 (11.6%) controls were diagnosed with SPCs over a mean follow-up of 6.9 years. Patients with thyroid cancer had a higher risk of SPC at any site (adjusted HR, 1.62; 95% CI, 1.60-1.64) than the controls. The risk of SPCs was particularly high for patients diagnosed with thyroid cancer at a younger age (<40 years) and within 5 years. Medical caregivers should consider the long-term follow-up of patients with thyroid cancer and discuss the risk of SPC, especially if they complain of cancer-related symptoms.

摘要

尽管甲状腺癌幸存者预后良好且预期寿命长,但仍可能发生后续原发性癌症(SPC)。我们调查了甲状腺癌患者发生SPC的风险和类型,并将其与无甲状腺癌病史的受试者(对照组)进行比较。我们基于韩国国民健康保险数据库进行了一项全国性的、基于人群的回顾性队列研究。2004年至2019年间共432,654例诊断为甲状腺癌的患者按年龄、性别、收入和居住地区与对照组进行1:1匹配。使用Cox比例风险模型估计SPC的风险比(HR)和95%置信区间(CI)。在平均6.9年的随访中,共有78,584例(18.2%)甲状腺癌患者和49,979例(11.6%)对照组患者被诊断为SPC。甲状腺癌患者在任何部位发生SPC的风险均高于对照组(校正HR,1.62;95%CI,1.60 - 1.64)。对于年龄较轻(<40岁)且在5年内诊断为甲状腺癌的患者,SPC的风险尤其高。医疗护理人员应考虑对甲状腺癌患者进行长期随访,并讨论SPC的风险,特别是当他们出现癌症相关症状时。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bd7/10527961/4015bb9d0683/diagnostics-13-02903-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bd7/10527961/1d958891b026/diagnostics-13-02903-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bd7/10527961/ae085433c7e9/diagnostics-13-02903-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bd7/10527961/4015bb9d0683/diagnostics-13-02903-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bd7/10527961/1d958891b026/diagnostics-13-02903-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bd7/10527961/ae085433c7e9/diagnostics-13-02903-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bd7/10527961/4015bb9d0683/diagnostics-13-02903-g003.jpg

相似文献

1
Risk of Subsequent Primary Cancer in Thyroid Cancer Survivors: A Nationwide Population-Based Study.甲状腺癌幸存者后续原发性癌症的风险:一项基于全国人口的研究。
Diagnostics (Basel). 2023 Sep 11;13(18):2903. doi: 10.3390/diagnostics13182903.
2
Risk of Subsequent Primary Cancers in Thyroid Cancer Survivors according to the Dose of Levothyroxine: A Nationwide Cohort Study.甲状腺癌幸存者根据左旋甲状腺素剂量发生继发原发性癌症的风险:一项全国性队列研究。
Endocrinol Metab (Seoul). 2024 Apr;39(2):288-299. doi: 10.3803/EnM.2023.1815. Epub 2024 Mar 4.
3
Racial and Ethnic Disparities in Survival Among People With Second Primary Cancer in the US.美国第二原发癌患者生存中的种族和民族差异。
JAMA Netw Open. 2023 Aug 1;6(8):e2327429. doi: 10.1001/jamanetworkopen.2023.27429.
4
Association of First Primary Cancer With Risk of Subsequent Primary Cancer Among Survivors of Adult-Onset Cancers in the United States.美国成年癌症患者中首次原发性癌症与随后发生的原发性癌症风险之间的关联。
JAMA. 2020 Dec 22;324(24):2521-2535. doi: 10.1001/jama.2020.23130.
5
Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study.韩国前列腺癌患者发生第二原发性癌症的风险:一项基于人群的队列研究。
PLoS One. 2015 Oct 15;10(10):e0140693. doi: 10.1371/journal.pone.0140693. eCollection 2015.
6
Prediagnosis obesity and secondary primary cancer risk in female cancer survivors: A national cohort study.诊断前肥胖与女性癌症幸存者继发原发性癌症风险:一项全国性队列研究。
Cancer Med. 2019 Feb;8(2):824-838. doi: 10.1002/cam4.1959. Epub 2019 Jan 16.
7
Association of first primary cancer with risk of subsequent primary cancer among survivors of adult-onset cancers in Kentucky and Appalachian Kentucky.肯塔基州及肯塔基州阿巴拉契亚地区成年期癌症幸存者中首次原发性癌症与后续原发性癌症风险的关联。
Front Oncol. 2023 Aug 17;13:1193487. doi: 10.3389/fonc.2023.1193487. eCollection 2023.
8
Mortality after second malignancy in breast cancer survivors compared to a first primary cancer: a nationwide longitudinal cohort study.乳腺癌幸存者继发第二原发性癌症后的死亡率与首次原发性癌症的比较:一项全国性纵向队列研究。
NPJ Breast Cancer. 2022 Jul 14;8(1):82. doi: 10.1038/s41523-022-00447-5.
9
Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.与索引型人乳头瘤病毒相关癌症相关的第二原发性癌症风险的趋势。
JAMA Netw Open. 2018 Sep 7;1(5):e181999. doi: 10.1001/jamanetworkopen.2018.1999.
10
Clinical and sociodemographic risk factors associated with the development of second primary cancers among postmenopausal breast cancer survivors.与绝经后乳腺癌幸存者第二原发癌发展相关的临床和社会人口学危险因素。
Breast Cancer. 2023 Mar;30(2):215-225. doi: 10.1007/s12282-022-01411-8. Epub 2022 Nov 1.

引用本文的文献

1
The onset characteristics and prognosis of patients with radiation-associated second primary malignancy: a pancancer study in the US SEER cancer registries.辐射相关第二原发性恶性肿瘤患者的发病特征及预后:美国监测、流行病学和最终结果(SEER)癌症登记处的一项全癌研究
Transl Cancer Res. 2024 Oct 31;13(10):5588-5599. doi: 10.21037/tcr-24-1618. Epub 2024 Oct 29.

本文引用的文献

1
Understanding and Utilizing Claim Data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) Database for Research.理解并利用韩国国民健康保险服务(NHIS)和健康保险审查与评估(HIRA)数据库中的理赔数据进行研究。
J Lipid Atheroscler. 2022 May;11(2):103-110. doi: 10.12997/jla.2022.11.2.103. Epub 2021 Nov 26.
2
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019.韩国癌症统计数据:2019 年的发病率、死亡率、生存率和流行率。
Cancer Res Treat. 2022 Apr;54(2):330-344. doi: 10.4143/crt.2022.128. Epub 2022 Mar 16.
3
Risk factors for second primary malignancies following thyroid cancer: a nationwide cohort study.
甲状腺癌患者发生第二原发恶性肿瘤的风险因素:一项全国性队列研究。
Eur J Endocrinol. 2022 Apr 1;186(5):561-571. doi: 10.1530/EJE-21-1208.
4
Risk of Second Primary Bone and Soft-Tissue Sarcomas Among Young Adulthood Cancer Survivors.青年癌症幸存者发生第二原发性骨肉瘤和软组织肉瘤的风险。
JNCI Cancer Spectr. 2019 Jun 20;3(3):pkz043. doi: 10.1093/jncics/pkz043. eCollection 2019 Sep.
5
Nonthyroidal second primary malignancies in differentiated thyroid cancer patients: Is the incidence increased comparing to the general population and could it be a radioiodine therapy consequence?分化型甲状腺癌患者的非甲状腺第二原发恶性肿瘤:与普通人群相比发病率是否增加,是否与放射性碘治疗有关?
Int J Cancer. 2020 Nov 15;147(10):2838-2846. doi: 10.1002/ijc.33116. Epub 2020 Jun 30.
6
A primer on the genetics of medullary thyroid cancer.《甲状腺髓样癌遗传学概论》。
Curr Oncol. 2019 Dec;26(6):389-394. doi: 10.3747/co.26.5553. Epub 2019 Dec 1.
7
Incidence of Hypoparathyroidism After Thyroid Cancer Surgery in South Korea, 2007-2016.2007-2016 年韩国甲状腺癌手术后甲状旁腺功能减退症的发病率。
JAMA. 2019 Dec 24;322(24):2441-2443. doi: 10.1001/jama.2019.19641.
8
A Systematic Review and Meta-Analysis of Subsequent Malignant Neoplasm Risk After Radioactive Iodine Treatment of Thyroid Cancer.放射性碘治疗甲状腺癌后恶性肿瘤风险的系统评价和荟萃分析。
Thyroid. 2018 Dec;28(12):1662-1673. doi: 10.1089/thy.2018.0244. Epub 2018 Nov 27.
9
Aging-Related Disease Risks among Young Thyroid Cancer Survivors.年轻甲状腺癌幸存者的与衰老相关疾病风险。
Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1695-1704. doi: 10.1158/1055-9965.EPI-17-0623. Epub 2017 Nov 22.
10
Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?分化型甲状腺癌患者的第二原发癌:碘 131 治疗是否起作用?
Thyroid. 2017 Aug;27(8):1068-1076. doi: 10.1089/thy.2016.0655. Epub 2017 Jul 14.